Biological active polypeptide SKLVPVGYGIRKL as well as preparation method and application thereof
本发明涉及蛋白领域,具体涉及一种生物活性多肽SKLVPVGYGIRKL及其制备方法和应用,生物活性多肽SKLVPVGYGIRKL其氨基酸序列为Ser‑Lys‑Leu‑Val‑Pro‑Val‑Gly‑Tyr‑Gly‑Ile‑Arg‑Lys‑Leu。经过体外免疫功能调节实验、体外抗炎实验,验证了多肽SKLVPVGYGIRKL具有较好的免疫调节功能和抗炎活性;一方面,本发明的生物活性多肽SKLVPVGYGIRKL能够促进巨噬细胞体外增殖,提高机体抵御外界病原体感染的能力,降低机体发病率;另一方面,能够提高巨噬细胞一氧化氮诱生量增加的能力,提高机体抵御外界异物侵入,降低机体生病的机率,对开发具有免疫调节功能、抗炎功能的食品、保健品和药物具有十分重要的意义。.
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Europäisches Patentamt - (2021) vom: 26. Juli Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Unbestimmt |
---|
Beteiligte Personen: |
ZHANG SHAOHUI [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2019, Last update posted on www.epo.org: 2021-07-26, Last updated: 2021-07-27 |
---|
Patentnummer: |
CN110938129 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA005890446 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA005890446 | ||
003 | DE-627 | ||
005 | 20230504135933.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210531s2021 xx |||||o 00| ||und c | ||
035 | |a (DE-627)EPA005890446 | ||
035 | |a (EPA)CN110938129 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a und | ||
100 | 0 | |a ZHANG SHAOHUI |e verfasserin |4 aut | |
245 | 1 | 0 | |a Biological active polypeptide SKLVPVGYGIRKL as well as preparation method and application thereof |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2019, Last update posted on www.epo.org: 2021-07-26, Last updated: 2021-07-27 | ||
520 | |a 本发明涉及蛋白领域,具体涉及一种生物活性多肽SKLVPVGYGIRKL及其制备方法和应用,生物活性多肽SKLVPVGYGIRKL其氨基酸序列为Ser‑Lys‑Leu‑Val‑Pro‑Val‑Gly‑Tyr‑Gly‑Ile‑Arg‑Lys‑Leu。经过体外免疫功能调节实验、体外抗炎实验,验证了多肽SKLVPVGYGIRKL具有较好的免疫调节功能和抗炎活性;一方面,本发明的生物活性多肽SKLVPVGYGIRKL能够促进巨噬细胞体外增殖,提高机体抵御外界病原体感染的能力,降低机体发病率;另一方面,能够提高巨噬细胞一氧化氮诱生量增加的能力,提高机体抵御外界异物侵入,降低机体生病的机率,对开发具有免疫调节功能、抗炎功能的食品、保健品和药物具有十分重要的意义。 | ||
650 | 4 | |a tec | |
650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
650 | 4 | |a A61Q: Specific use of cosmetics or similar toilet preparations | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a che | |
650 | 4 | |a A23L: Foods, foodstuffs, or non-alcoholic beverages, not covered by subclasses a21d or a23b-a23j; their preparation or treatment, e.g. cooking, modification of nutritive qualities, physical treatment (shaping or working, not fully covered by this subclass, a23p); preservation of foods or foodstuffs, in general | |
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a 615 | |
700 | 0 | |a ZHAN WENJING |e verfasserin |4 aut | |
700 | 0 | |a TANG YI |e verfasserin |4 aut | |
700 | 0 | |a FAN MENGZHU |e verfasserin |4 aut | |
700 | 0 | |a ZHANG BOYU |e verfasserin |4 aut | |
700 | 0 | |a LUAN YUANYUAN |e verfasserin |4 aut | |
700 | 0 | |a GUO TINGTING |e verfasserin |4 aut | |
700 | 0 | |a WANG CHAO |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 26. Juli |
773 | 1 | 8 | |g year:2021 |g day:26 |g month:07 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/searchResults?DB=EPODOC&locale=en_EP&query=CN110938129A |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2021 |b 26 |c 07 |
951 | |a AR | ||
952 | |j 2021 |b 26 |c 07 |